Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

Awareness of, and Compliance with, Domperidone Revised Labeling After a Risk-Minimization Activity in Europe.

Fife D, Waller J, Kaplan S, Hu P, Phillips S, Oliveria SA, Richarz U.

Clin Drug Investig. 2019 Jul 19. doi: 10.1007/s40261-019-00831-3. [Epub ahead of print]

PMID:
31325111
2.

Validating an algorithm for multiple myeloma based on administrative data using a SEER tumor registry and medical record review.

Brandenburg NA, Phillips S, Wells KE, Woodcroft KJ, Amend KL, Enger C, Oliveria SA.

Pharmacoepidemiol Drug Saf. 2019 Feb;28(2):256-263. doi: 10.1002/pds.4711. Epub 2019 Feb 4.

PMID:
30719785
3.

Treatment patterns, adherence, and persistence among psoriasis patients treated with biologics in a real-world setting, overall and by disease severity.

Murage MJ, Anderson A, Casso D, Oliveria SA, Ojeh CK, Muram TM, Merola JF, Zbrozek A, Araujo AB.

J Dermatolog Treat. 2019 Mar;30(2):141-149. doi: 10.1080/09546634.2018.1479725. Epub 2018 Jul 23.

PMID:
29799292
4.

Healthcare resource utilization and costs among psoriasis patients treated with biologics, overall and by disease severity.

Murage MJ, Anderson A, Oliveria SA, Casso D, Ojeh CK, Muram TM, Merola JF, Araujo AB.

J Med Econ. 2018 Aug;21(8):745-754. doi: 10.1080/13696998.2018.1472097. Epub 2018 May 22.

PMID:
29718756
5.

Melanoma Thickness and Survival Trends in the United States, 1989 to 2009.

Shaikh WR, Dusza SW, Weinstock MA, Oliveria SA, Geller AC, Halpern AC.

J Natl Cancer Inst. 2015 Nov 12;108(1). pii: djv294. doi: 10.1093/jnci/djv294. Print 2016 Jan.

6.

Sunburn, sun exposure, and sun sensitivity in the Study of Nevi in Children.

Satagopan JM, Oliveria SA, Arora A, Marchetti MA, Orlow I, Dusza SW, Weinstock MA, Scope A, Geller AC, Marghoob AA, Halpern AC.

Ann Epidemiol. 2015 Nov;25(11):839-43. doi: 10.1016/j.annepidem.2015.05.004. Epub 2015 May 23.

7.

Dermatoscopic imaging of skin lesions by high school students: a cross-sectional pilot study.

Marchetti MA, Fonseca M, Dusza SW, Scope A, Geller AC, Bishop M, Marghoob AA, Oliveria SA, Halpern AC.

Dermatol Pract Concept. 2015 Jan 30;5(1):11-28. doi: 10.5826/dpc.0501a02. eCollection 2015 Jan.

8.

Incidence of liver injury among cancer patients receiving chemotherapy in an integrated health system.

Ulcickas Yood M, Bortolini M, Casso D, Beck JG, Oliveria SA, Wells KE, Woodcroft KJ, Wang LI.

Pharmacoepidemiol Drug Saf. 2015 Apr;24(4):427-34. doi: 10.1002/pds.3757. Epub 2015 Feb 12.

PMID:
25683797
9.

Feasibility and Efficacy of Patient-Initiated Mobile Teledermoscopy for Short-term Monitoring of Clinically Atypical Nevi.

Wu X, Oliveria SA, Yagerman S, Chen L, DeFazio J, Braun R, Marghoob AA.

JAMA Dermatol. 2015 May;151(5):489-96. doi: 10.1001/jamadermatol.2014.3837.

PMID:
25629626
10.

Biopsies of nevi in children and adolescents in the United States, 2009 through 2013.

Oliveria SA, Selvam N, Mehregan D, Marchetti MA, Divan HA, Dasgeb B, Halpern AC.

JAMA Dermatol. 2015 Apr;151(4):447-8. doi: 10.1001/jamadermatol.2014.4576. No abstract available.

PMID:
25494368
11.

Genetic factors associated with naevus count and dermoscopic patterns: preliminary results from the Study of Nevi in Children (SONIC).

Orlow I, Satagopan JM, Berwick M, Enriquez HL, White KA, Cheung K, Dusza SW, Oliveria SA, Marchetti MA, Scope A, Marghoob AA, Halpern AC.

Br J Dermatol. 2015 Apr;172(4):1081-9. doi: 10.1111/bjd.13467. Epub 2015 Feb 15.

12.

Factors associated with nevus volatility in early adolescence.

Oliveria SA, Scope A, Satagopan JM, Geller AC, Dusza SW, Weinstock MA, Berwick M, Bishop M, Marghoob AA, Halpern AC.

J Invest Dermatol. 2014 Sep;134(9):2469-2471. doi: 10.1038/jid.2014.189. Epub 2014 Apr 14. No abstract available.

13.

Patient characteristics and participation in a genetic study: a type 2 diabetes cohort.

Amiri L, Cassidy-Bushrow AE, Dakki H, Li J, Wells K, Oliveria SA, Yood MU, Thomas A, Lanfear DE.

J Investig Med. 2014 Jan;62(1):26-32. doi: 10.2310/JIM.0000000000000022.

14.

Patient perceptions of nonmelanoma skin cancer before diagnosis.

Yancovitz M, Rizzo C, Julian P, Oliveria SA, Becker D.

Dermatol Surg. 2013 Oct;39(10):1496-501. doi: 10.1111/dsu.12311. Epub 2013 Sep 24.

PMID:
24090260
15.

Clinical and dermoscopic characteristics of new naevi in adults: results from a cohort study.

Oliveria SA, Yagerman SE, Jaimes N, Goodwin AI, Dusza SW, Halpern AC, Marghoob AA.

Br J Dermatol. 2013 Oct;169(4):848-53. doi: 10.1111/bjd.12482.

PMID:
23796324
16.

Change in dermoscopic pattern of naevi in children: a commentary.

Scope A, Marghoob AA, Dusza SW, Oliveria SA, Halpern AC.

Acta Derm Venereol. 2014 Jan;94(1):120-2. doi: 10.2340/00015555-1630. No abstract available.

17.

Melanoma survivors: health behaviors, surveillance, psychosocial factors, and family concerns.

Oliveria SA, Shuk E, Hay JL, Heneghan M, Goulart JM, Panageas K, Geller AC, Halpern AC.

Psychooncology. 2013 Jan;22(1):106-16. doi: 10.1002/pon.2059. Epub 2011 Oct 6.

18.

The characterization and potential impact of melanoma cases with unknown thickness in the United States' Surveillance, Epidemiology, and End Results Program, 1989-2008.

Shaikh WR, Weinstock MA, Halpern AC, Oliveria SA, Geller AC, Dusza SW.

Cancer Epidemiol. 2013 Feb;37(1):64-70. doi: 10.1016/j.canep.2012.08.010. Epub 2012 Sep 18.

PMID:
22995853
19.

Cardiovascular outcomes in women with advanced breast cancer exposed to chemotherapy.

Yood MU, Wells KE, Alford SH, Dakki H, Beiderbeck AB, Hurria A, Gross CP, Oliveria SA.

Pharmacoepidemiol Drug Saf. 2012 Aug;21(8):818-27. doi: 10.1002/pds.3239. Epub 2012 Mar 15.

20.

Prospective study of sunburn and sun behavior patterns during adolescence.

Dusza SW, Halpern AC, Satagopan JM, Oliveria SA, Weinstock MA, Scope A, Berwick M, Geller AC.

Pediatrics. 2012 Feb;129(2):309-17. doi: 10.1542/peds.2011-0104. Epub 2012 Jan 23.

21.

Communication about family members' risk of melanoma: self-reported practices of dermatologists in the United States.

Oliveria SA, Heneghan MK, Halpern AC, Hay JL, Geller AC.

Arch Dermatol. 2012 May;148(5):621-7. doi: 10.1001/archdermatol.2011.2515.

PMID:
22250188
22.

Association between second-generation antipsychotics and newly diagnosed treated diabetes mellitus: does the effect differ by dose?

Ulcickas Yood M, Delorenze GN, Quesenberry CP Jr, Oliveria SA, Tsai AL, Kim E, Cziraky MJ, McQuade RD, Newcomer JW, L'italien GJ.

BMC Psychiatry. 2011 Dec 15;11:197. doi: 10.1186/1471-244X-11-197.

23.

Adherence to treatment with second-line therapies, dasatinib and nilotinib, in patients with chronic myeloid leukemia.

Yood MU, Oliveria SA, Cziraky M, Hirji I, Hamdan M, Davis C.

Curr Med Res Opin. 2012 Feb;28(2):213-9. doi: 10.1185/03007995.2011.649849. Epub 2012 Jan 9.

PMID:
22168217
24.

Properties of preliminary test estimators and shrinkage estimators for evaluating multiple exposures - Application to questionnaire data from the 'Study of nevi in children' (SONIC) study.

Satagopan JM, Zhou Q, Oliveria SA, Dusza SW, Weinstock MA, Berwick M, Halpern AC.

J R Stat Soc Ser C Appl Stat. 2011 Aug 1;60(4):619-632.

25.

Safety during dermatologic procedures and surgeries: a survey of resident injuries and prevention strategies.

Goulart JM, Oliveria SA, Levitt J.

J Am Acad Dermatol. 2011 Sep;65(3):648-650. doi: 10.1016/j.jaad.2011.03.021. No abstract available.

PMID:
21839322
26.

Clinical and dermoscopic stability and volatility of melanocytic nevi in a population-based cohort of children in Framingham school system.

Scope A, Dusza SW, Marghoob AA, Satagopan JM, Braga Casagrande Tavoloni J, Psaty EL, Weinstock MA, Oliveria SA, Bishop M, Geller AC, Halpern AC.

J Invest Dermatol. 2011 Aug;131(8):1615-21. doi: 10.1038/jid.2011.107. Epub 2011 May 12.

27.

Skin cancer screening by dermatologists, family practitioners, and internists: barriers and facilitating factors.

Oliveria SA, Heneghan MK, Cushman LF, Ughetta EA, Halpern AC.

Arch Dermatol. 2011 Jan;147(1):39-44. doi: 10.1001/archdermatol.2010.414.

PMID:
21242390
28.

Epidemiologic study of aripiprazole use and the incidence of suicide events.

Ulcickas Yood M, Delorenze G, Quesenberry CP Jr, Tsai AL, Phillips S, Willey VJ, Niemcryk SJ, Wells K, Skovron ML, Cziraky MJ, Carson W, Oliveria SA.

Pharmacoepidemiol Drug Saf. 2010 Nov;19(11):1124-30. doi: 10.1002/pds.2047.

PMID:
20925132
29.

Use of and beliefs about total body photography and dermatoscopy among US dermatology training programs: an update.

Terushkin V, Oliveria SA, Marghoob AA, Halpern AC.

J Am Acad Dermatol. 2010 May;62(5):794-803. doi: 10.1016/j.jaad.2009.09.008. Epub 2010 Mar 12.

PMID:
20223561
30.

The incidence of diabetes in atypical antipsychotic users differs according to agent--results from a multisite epidemiologic study.

Yood MU, DeLorenze G, Quesenberry CP Jr, Oliveria SA, Tsai AL, Willey VJ, McQuade R, Newcomer J, L'Italien G.

Pharmacoepidemiol Drug Saf. 2009 Sep;18(9):791-9. doi: 10.1002/pds.1781.

PMID:
19526626
31.

Sun protection and skin self-examination in melanoma survivors.

Mujumdar UJ, Hay JL, Monroe-Hinds YC, Hummer AJ, Begg CB, Wilcox HB, Oliveria SA, Berwick M.

Psychooncology. 2009 Oct;18(10):1106-15. doi: 10.1002/pon.1510.

32.

Study of Nevi in Children (SONIC): baseline findings and predictors of nevus count.

Oliveria SA, Satagopan JM, Geller AC, Dusza SW, Weinstock MA, Berwick M, Bishop M, Heneghan MK, Halpern AC.

Am J Epidemiol. 2009 Jan 1;169(1):41-53. doi: 10.1093/aje/kwn289. Epub 2008 Nov 10.

33.

Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations.

Arellano FM, Yood MU, Wentworth CE, Oliveria SA, Rivero E, Arana A, Rothman KJ.

Pharmacoepidemiol Drug Saf. 2008 Oct;17(10):1037. doi: 10.1002/pds.1636. No abstract available.

PMID:
18816876
34.

Melanoma survivorship: research opportunities.

Oliveria SA, Hay JL, Geller AC, Heneghan MK, McCabe MS, Halpern AC.

J Cancer Surviv. 2007 Mar;1(1):87-97. doi: 10.1007/s11764-007-0009-y.

PMID:
18648948
35.

Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors.

Miller DR, Oliveria SA, Berlowitz DR, Fincke BG, Stang P, Lillienfeld DE.

Hypertension. 2008 Jun;51(6):1624-30. doi: 10.1161/HYPERTENSIONAHA.108.110270. Epub 2008 Apr 14.

PMID:
18413488
36.

Dermoscopic patterns of naevi in fifth grade children of the Framingham school system.

Scope A, Marghoob AA, Dusza SW, Satagopan JM, Agero AL, Benvenuto-Andrade C, Lieb JA, Weinstock MA, Oliveria SA, Geller AC, Halpern AC.

Br J Dermatol. 2008 May;158(5):1041-9. doi: 10.1111/j.1365-2133.2008.08510.x. Epub 2008 Mar 20.

PMID:
18363751
37.

Complex dermoscopic pattern: a potential risk marker for melanoma.

Lipoff JB, Scope A, Dusza SW, Marghoob AA, Oliveria SA, Halpern AC.

Br J Dermatol. 2008 Apr;158(4):821-4. doi: 10.1111/j.1365-2133.2007.08404.x. Epub 2008 Jan 17.

PMID:
18205864
38.

Barriers to the initiation of, and persistence with, insulin therapy.

Oliveria SA, Menditto LA, Ulcickas Yood M, Koo YH, Wells KE, McCarthy BD.

Curr Med Res Opin. 2007 Dec;23(12):3105-12.

PMID:
17977482
39.

Skin cancer coverage in a national newspaper: a teachable moment.

Heneghan MK, Hazan C, Halpern AC, Oliveria SA.

J Cancer Educ. 2007 Summer;22(2):99-104.

PMID:
17605623
40.

Study of health outcomes in school children: key challenges and lessons learned from the Framingham Schools' Natural History of Nevi Study.

Geller AC, Oliveria SA, Bishop M, Buckminster M, Brooks KR, Halpern AC.

J Sch Health. 2007 Aug;77(6):312-8.

PMID:
17600588
41.

Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile.

Arellano FM, Yood MU, Wentworth CE, Oliveria SA, Rivero E, Verma A, Rothman KJ.

Pharmacoepidemiol Drug Saf. 2006 Dec;15(12):861-72.

PMID:
17086563
42.

Differential associations of beta-blockers with hemorrhagic events for chronic heart failure patients on warfarin.

Berlowitz DR, Miller DR, Oliveria SA, Cunningham F, Gomez-Caminero A, Rothendler JA.

Pharmacoepidemiol Drug Saf. 2006 Nov;15(11):799-807.

PMID:
16892457
43.

Adverse events among nursing home residents with Alzheimer's disease and psychosis.

Oliveria SA, Liperoti R, L'italien G, Pugner K, Safferman A, Carson W, Lapane K.

Pharmacoepidemiol Drug Saf. 2006 Nov;15(11):763-74.

PMID:
16823890
44.

Psychosocial mediators of a nurse intervention to increase skin self-examination in patients at high risk for melanoma.

Hay JL, Oliveria SA, Dusza SW, Phelan DL, Ostroff JS, Halpern AC.

Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1212-6.

45.

Sun exposure and risk of melanoma.

Oliveria SA, Saraiya M, Geller AC, Heneghan MK, Jorgensen C.

Arch Dis Child. 2006 Feb;91(2):131-8. Epub 2005 Dec 2. Review.

46.

Clinical and dermoscopic changes in common melanocytic nevi in school children: the Framingham school nevus study.

LaVigne EA, Oliveria SA, Dusza SW, Geller AC, Halpern AC, Marghoob AA.

Dermatology. 2005;211(3):234-9.

PMID:
16205068
47.

Variation in the diagnosis, treatment, and management of melanoma in situ: a survey of US dermatologists.

Charles CA, Yee VS, Dusza SW, Marghoob AA, Oliveria SA, Kopf A, Rigel D, Halpern AC.

Arch Dermatol. 2005 Jun;141(6):723-9.

PMID:
15967918
48.

Patient experiences with photo books in monthly skin self-examinations.

Phelan DL, Oliveria SA, Halpern AC.

Dermatol Nurs. 2005 Apr;17(2):109-14.

PMID:
15916185
49.

Barriers to hypertension control.

Borzecki AM, Oliveria SA, Berlowitz DR.

Am Heart J. 2005 May;149(5):785-94. Review. No abstract available.

PMID:
15894958
50.

Student-parent agreement in self-reported sun behaviors.

Dusza SW, Oliveria SA, Geller AC, Marghoob AA, Halpern AC.

J Am Acad Dermatol. 2005 May;52(5):896-900.

PMID:
15858486

Supplemental Content

Loading ...
Support Center